Autoimmune and inflammatory mechanisms in atherosclerosis

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 361-403

  Wick, Georg ^a   Knoflach, Michael ^a   Xu, Qingbo ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aging; Heat shock proteins; Infections; Inflammation; Signal transduction

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CYCLOSPORIN A; HEAT SHOCK PROTEIN 60; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INFLAMMATION; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ANIMALS; ARTERIOSCLEROSIS; AUTOIMMUNITY; CHAPERONIN 60; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 2542498855     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104644     Document Type: Review

References (220)

1. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, et al. 1995. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15:1512-31
2. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, et al. 1994. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:2462-78
3. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA 84:2995-98
4. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. 2003. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J. Immunol. 170:2302-9
5. Nieto FJ. 1998. Infections and atherosclerosis: new clues from an old hypothesis? Am. J. Epidemiol. 148:937-48
6. Knoflach M, Mayrl B, Mayerl C, Sedivy R, Wick G. 2003. Atherosclerosis as a paradigmatic disease of the elderly: role of the immune system. Immunol. Allergy Clin. North Am. 23:117-32
7. Ross R, Glomset JA. 1976. The pathogenesis of atherosclerosis (first of two parts). N. Engl. J. Med. 295:369-77
8. Ross R, Glomset JA. 1976. The pathogenesis of atherosclerosis (second of two parts). N. Engl. J. Med. 295:420-25
9. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, et al. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983-86
10. Shi W, Wang NJ, Shih DM, Sun VZ, Wang X, Lusis AJ. 2000. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ. Res. 86:1078-84
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:915-24
12. Witztum JL, Steinberg D. 2001. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? Trends Cardiovasc. Med. 11:93-102
13. Benditt EP, Benditt JM. 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 70:1753-56
14. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. 1995. Is atherosclerosis an immunologically mediated disease? Immunol. Today 16:27-33
15. Wick G, Romen M, Amberger A, Metzler B, Mayr M, et al. 1997. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 11:1199-207
16. Xu QB, Oberhuber G, Gruschwitz M, Wick G. 1990. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 56:344-59
17. van der Wal AC, Das PK, Bentz vdB, van der Loos CM, Becker AE. 1989. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab. Invest. 61:166-70
18. Kleindienst R, Xu Q, Willeit J, Waldenberger FR, Weimann S, Wick G. 1993. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am. J. Pathol. 142:1927-37
19. Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH. 2003. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23:454-60
20. Capron L. 1991. Leukocytes and arteriosclerosis. Arch. Mal Coeur Vaiss. 84:1845-50
21. Metzler B, Xu Q. 1997. The role of mast cells in atherosclerosis. Int. Arch. Allergy Immunol. 114:10-14
22. Wissler RW, Strong JP. 1998. Risk factors and progression of atherosclerosis in youth. PDAY Research Group. Pathological Determinants of Atherosclerosis in Youth. Am. J. Pathol. 153:1023-33
23. Bobryshev YV, Lord RS, Rainer S, Jamal OS, Munro VF. 1996. Vascular dendritic cells and atherosclerosis. Pathol. Res. Pract. 192:462-67
24. Aicher A, Heeschen C, Mohaupt M, Cooke JP, Zeiher AM, Dimmeler S. 2003. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 107:604-11
25. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-45
26. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, et al. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107:1255-62
27. Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, et al. 1997. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99:1037-43
28. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaud AL. 2000. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med. 191:189-94
29. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, et al. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2:275-81
30. Dawson TC, Kuziel WA, Osahar TA, Maeda N. 1999. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143:205-11
31. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87:5134-38
32. Millonig G, Niederegger H, Rabl W, Hochleitner BW, Hoefer D, et al. 2001. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler. Thromb. Vasc. Biol. 21:503-8
33. Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. 1999. Human 60-kDa heatshock protein: a danger signal to the innate immune system. J. Immunol. 162:3212-19
34. Seifert PS, Kazatchkine MD. 1988. The complement system in atherosclerosis. Atherosclerosis 73:91-104
35. Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, et al. 2002. Influence of C3 deficiency on atherosclerosis. Circulation 105:3025-31
36. Ridker PM, Hennekens CH, Buring JE, Rifai N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:836-43
37. Ridker PM, Stampfer MJ, Rifai N. 2001. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481-85
38. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, et al. 2001. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103:1064-70
39. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103:117-28
40. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. 2000. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176:154-70
41. Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, et al. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9:736-43
42. Ishida T, Yasukawa K, Kojima H, Harashima H, Kiwada H. 2001. Effect of cholesterol content in activation of the classical versus the alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes. Int. J. Pharm. 224:69-79
43. Seifert PS, Hansson GK. 1989. Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis 9:802-11
44. Vlaicu R, Rus HG, Niculescu F, Cristea A. 1985. Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55:35-50
45. Minick CR, Murphy GE. 1973. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. II. Effect of repeatedly injected foreign protein in rabbits fed a lipid-rich, cholesterol-poor diet. Am. J. Pathol. 73:265-300
46. Stemme S, Rymo L, Hansson GK. 1991. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65:654-60
47. Paulsson G, Zhou X, Tornquist E, Hansson GK. 2000. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20:10-17
48. Pinderski LJ, Fischbein MP, Subbanagounder G, Fishbein MC, Kubo N, et al. 2002. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90:1064-71
49. Huber SA, Sakkinen P, David C, Newell MK, Tracy RP. 2001. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103:2610-16
50. Xu Q, Wick G, Wachter H, Reibnegger G. 1994. Relationship among serum hsp65 antibodies, neopterin, autoantibodies and atherosclerosis. Pteridines 5:139-41
51. Smith DA, Zouridakis EG, Mariani M, Fredericks S, Cole D, Kaski JC. 2003. Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity. Am. Heart J. 146:69-74
52. Teramoto S, Yamamoto H, Ouchi Y. 2003. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 107:E40
53. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, et al. 2001. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89:930-34
54. Dansky HM, Charlton SA, Harper MM, Smith JD. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94:4642-46
55. -/- mice. J. Clin. Invest. 100:1575-80
56. Wick G, Xu Q. 2002. Autoimmunity in Atherosclerosis. In The Molecular Pathology of Autoimmune Diseases, ed. CA Bona, AN Theofilopoulos, pp. 965-77. New York: Taylor & Francis
57. Metzler B, Mayr M, Dietrich H, Singh M, Wiebe E, et al. 1999. Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 19:1905-11
58. Wick G. 2001. Correction for Metzler et al., Arterioscler Thromb Vasc Biol 19 (8) 1905-11. Arterioscler. Thromb. Vasc. Biol. 21:1706
59. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. 2002. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109:745-53
60. Nicoletti A, Caligiuri G, Paulsson G, Hansson GK. 1999. Functionality of specific immunity in atherosclerosis. Am. Heart J. 138:8438-43
61. Witztum JL. 2002. Splenic immunity and atherosclerosis: a glimpse into a novel paradigm? J. Clin. Invest. 109:721-24
62. Wick G, Xu Q. 1999. Atherosclerosis - an autoimmune disease. Exp. Gerontol. 34:559-66
63. George J, Harats D, Gilburd B, Afek A, Shaish A, et al. 2000. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102:1822-27
64. Palinski W, Miller E, Witztum JL. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 92:821-25
65. Uusitupa MI, Niskanen L, Luoma J, Vilja P, Mercuri M, et al. 1996. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in noninsulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 16:1236-42
66. Witztum JL. 1997. Immunological response to oxidized LDL. Atherosclerosis 131(Suppl.):S9-11
67. Craig EA, Gambill BD, Nelson RJ. 1993. Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol. Rev. 57:402-14
68. Benjamin IJ, McMillan DR. 1998. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ. Res. 83:117-32
69. Xu Q, Wick G. 1996. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol. Med. Today 2:372-79
70. Hartl FU, Hayer-Hartl M. 2002. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-58
71. Young RA, Elliott TJ. 1989. Stress proteins, infection, and immune surveillance. Cell 59:5-8
72. Rocnik E, Chow LH, Pickering JG. 2000. Heat shock protein 47 is expressed in fibrous regions of human atheroma and is regulated by growth factors and oxidized low-density lipoprotein. Circulation 101:1229-33
73. Johnson AD, Berberian PA, Tytell M, Bond MG. 1993. Atherosclerosis alters the localization of HSP70 in human and macaque aortas. Exp. Mol. Pathol. 58:155-68
74. Bartz SR, Pauza CD, Ivanyi J, Jindal S, Welch WJ, Malkovsky M. 1994. An Hsp60 related protein is associated with purified HIV and SIV. J. Med. Primatol. 23:151-54
75. Wick G, Kleindienst R, Schett G, Amberger A, Xu Q. 1995. Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. Int. Arch. Allergy Immunol. 107:130-31
76. Liao DF, Jin ZG, Baas AS, Daum G, Gygi SP, et al. 2000. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 275:189-96
77. Xu Q, Schert G, Perschinka H, Mayr M, Egger G, et al. 2000. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102:14-20
78. Amberger A, Maczek C, Jurgens G, Michaelis D, Schett G, et al. 1997. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones. 2:94-103
79. Soltys BJ, Gupta RS. 1997. Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol. Int. 21:315-20
80. Xu Q, Schett G, Seitz CS, Hu Y, Gupta RS, Wick G. 1994. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ. Res. 75:1078-85
81. Seitz CS, Kleindienst R, Xu Q, Wick G. 1996. Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab. Invest. 74:241-52
82. Xu Q. 2002. Role of heat shock proteins in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22:1547-59
83. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, et al. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168:1435-40
84. Habich C, Baumgart K, Kolb H, Burkart V. 2002. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J. Immunol. 168:569-76
85. Kiechl S, Willeit J. 1999. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler. Thromb. Vasc. Biol. 19:1484-90
86. Kiechl S, Willeit J. 1999. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler. Thromb. Vasc. Biol. 19:1491-98
87. Kiechl S, Lorenz E, Reindl M, Weidermann CJ, Oberhollenzer F, et al. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347:185-92
88. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, et al. 1992. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 12:789-99
89. Goodall JC, Bledsoe P, Gaston JS. 1999. Tracking antigen-specific human T lymphocytes in rheumatoid arthritis by T cell receptor analysis. Hum. Immunol. 60:798-805
90. Van der Zee R, Anderton SM, Prakken AB, Liesbeth Paul AG, van Eden W. 1998. T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity. Semin. Immunol. 10:35-41
91. Xu Q, Kleindienst R, Schett G, Waitz W, Jindal S, et al. 1996. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 123:145-55
92. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. 1993. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91:2693-702
93. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-71
94. Breslow JL. 1993. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc. Natl. Acad. Sci. USA 90:8314-18
95. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, et al. 1999. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler. Thromb. Vasc. Biol. 19:505-10
96. George J, Afek A, Gilburd B, Levkovitz H, Shaish A, et al. 1998. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138(1):147-52
97. George J, Afek A, Gilburd B, Shoenfeld Y, Karats D. 2001. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 38:900-5
98. Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J. 2002. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 40:1333-38
99. Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, et al. 2002. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106:1708-15
100. Barker RN, Easterfield AJ, Allen RF, Wells AD, Elson CJ, Thompson SJ. 1996. B- and T-cell autoantigens in pristane-induced arthritis. Immunology 89:189-94
101. Anderton SM, Van der Zee R, Prakken B, Noordzij A, van Eden W. 1995. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J. Exp. Med. 181:943-52
102. Gaston JS. 1998. Role of T-cells in the development of arthritis. Clin. Sci. (London) 95:19-31
103. Berberian PA, Myers W, Tytell M, Challa V, Bond MG. 1990. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am. J. Pathol. 136:71-80
104. Bobryshev YV, Lord RS. 2002. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J. Vasc. Surg. 35:368-75
105. Kanwar RK, Kanwar JR, Wang D, Ormrod DJ, Krissansen GW. 2001. Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:1991-97
106. Baler R, Dahl G, Voellmy R. 1993. Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Mol. Cell Biol. 13:2486-96
107. Pirkkala L, Nykanen P, Sistonen L. 2001. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 15:1118-31
108. Metzler B, Abia R, Ahmad M, Wernig F, Pachinger O, Hu Y, Xu Q. 2003. Activation of heat shock transcription factor 1 in atherosclerosis. Am. J. Pathol. 162:1669-76
109. Chu B, Soncin F, Price BD, Stevenson MA, Calderwood SK. 1996. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J. Biol. Chem. 271:30847-57
110. Hu Y, Metzler B, Xu Q. 1997. Discordant activation of stress-activated protein kinases or c-Jun NH2-terminal protein kinases in tissues of heat-stressed mice. J. Biol. Chem. 272:9113-19
111. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. 1996. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J. Biol. Chem. 271:4138-42
112. Metzler B, Li C, Hu Y, Sturm G, Ghaffari-Tabrizi N, Xu Q. 1999. LDL stimulates mitogen-activated protein kinase phosphatase-1 expression, independent of LDL receptors, in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:1862-71
113. Metzler B, Hu Y, Sturm G, Wick G, Xu Q. 1998. Induction of mitogen-activated protein kinase phosphatase-1 by arachidonic acid in vascular smooth muscle cells. J. Biol. Chem. 273:33320-26
114. Hu Y, Dietrich H, Metzler B, Wick G, Xu Q. 2000. Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 20:18-26
115. Metzler B, Hu Y, Dietrich H, Xu Q. 2000. Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53. Am. J. Pathol. 156:1875-86
116. Li C, Hu Y, Mayr M, Xu Q. 1999. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J. Biol. Chem. 274:25273-80
117. Madamanchi NR, Li S, Patterson C, Runge MS. 2001. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler. Thromb. Vasc. Biol. 21:321-26
118. Di Cesare S, Poccia F, Mastino A, Colizzi V. 1992. Surface expressed heat-shock proteins by stressed or human immunodeficiency virus (HIV)-infected lymphoid cells represent the target for antibody-dependent cellular cytotoxicity. Immunology 76:341-43
119. Soltys BJ, Gupta RS. 1996. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp. Cell Res. 222:16-27
120. Khan IU, Wallin R, Gupta RS, Kammer GM. 1998. Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane. Proc. Natl. Acad. Sci. USA 95:10425-30
121. Schett G, Metzler B, Kleindienst R, Amberger A, Recheis H, et al. 1999. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc. Res. 42:685-95
122. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, et al. 1993. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341:255-59
123. Xu Q, Kiechl S, Mayr M, Metzler B, Egger G, et al. 1999. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100:1169-74
124. Schett G, Metzler B, Kleindienst R, Moschen I, Hattmannsdorfer R, et al. 1997. Salivary anti-hsp65 antibodies as a diagnostic marker for gingivitis and a possible link to atherosclerosis. Int. Arch. Allergy Immunol. 114:246-50
125. Hoppichler F, Lechleitner M, Traweger C, Schett G, Dzien A, et al. 1996. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 126:333-38
126. Mukherjee M, De Benedictis C, Jewitt D, Kakkar VV. 1996. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis. Thromb. Haemost. 75:258-60
127. Metzler B, Schett G, Kleindienst R, Van der Zee R, Ottenhoff T, Hajeer A, et al. 1997. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:536-41
128. Perschinka H, Mayr M, Millonig G, Mayerl C, Van der Zee R, Morrison SG, et al. 2003. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23:1060-65
129. Kocsis J, Veres A, Vatay A, Duba J, Karadi I, et al. 2002. Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease. Immunol. Invest. 31:219-31
130. Chan YC, Shukla N, Abdus-Samee M, Berwanger CS, Stanford J, et al. 1999. Anti-heat-shock protein 70 kDa antibodies in vascular patients. Eur. J. Vasc. Endovasc. Surg. 18:381-85
131. Knoflach M, Kiechl S, Kind M, Said M, Sief R, et al. 2003. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 108(9):1064-69
132. Wick G, Kromer G, Neu N, Fassler R, Ziemiecki A, et al. 1987. The multifactorial pathogenesis of autoimmune disease. Immunol. Lett. 16:249-57
133. Mackenzie WA, Davies TF. 1987. An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunology 61:101-3
134. Boullier A, Gillotte KL, Horkko S, Green SR, Friedman P, et al. 2000. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275:9163-69
135. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. 2003. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278:1561-68
136. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, et al. 2001. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann. NY Acad. Sci. 947:214-22
137. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, et al. 2002. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277:38517-23
138. Steinberg D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8:1211-17
139. McMurray HF, Parthasarathy S, Steinberg D. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1004-8
140. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3:215-22
141. Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, et al. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:1731-40
142. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14:32-40
143. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, et al. 2001. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 103:2277-82
144. Palinski W, Witztum JL. 2000. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med. 247:371-80
145. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 92:3893-97
146. Zhou X, Stemme S, Hansson GK. 1996. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E- deficient mice. Am. J. Pathol. 149:359-66
147. Epstein SE, Zhou YF, Zhu J. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:E20-28
148. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. 1998. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 98:845-50
149. Danesh J, Collins R, Peto R. 1997. Chronic infections and coronary heart disease: is there a link? Lancet 350:430-36
150. Danesh J, Peto R. 1998. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130-32
151. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. 2001. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45-51
152. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, et al. 2002. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15-21
153. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. 2000. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler. Thromb. Vasc. Biol. 20:1417-20
154. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1614-20
155. Shor A. 2001. Mechanism of arterial infection by Chlamydia pneumoniae. Circulation 104:E75
156. Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, et al. 1998. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 98:628-33
157. Hu H, Pierce GN, Zhong G. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103:747-53
158. Kol A, Bourcier T, Lichtman AH, Libby P. 1999. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103:571-77
159. Gura T. 1998. Infections: a cause of artery-clogging plaques? Science 281:35-37
160. Kol A, Sukhova GK, Lichtman AH, Libby P. 1998. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98:300-7
161. Curry AJ, Portig I, Goodall JC, Kirkpatrick PJ, Gaston JS. 2000. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin. Exp. Immunol. 121:261-69
162. Millonig G, Malcom GT, Wick G. 2002. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 160:441-48
163. Waltner-Romen M, Falkensammer G, Rabl W, Wick G. 1998. A previously unrecognized site of local accumulation of mononuclear cells. The vascular-associated lymphoid tissue. J. Histochem. Cytochem. 46:1347-50
164. Bobryshev YV. 2000. Identification of HIV-1 in the aortic wall of AIDS patients. Atherosclerosis 152:529-30
165. Koperek O, Kovacs GG, Ritchie D, Ironside JW, Budka H, Wick G. 2002. Disease-associated prion protein in vessel walls. Am. J. Pathol. 161:1979-84
166. Millonig G, Schwentner C, Mueller P, Mayerl C, Wick G. 2001. The vascular-associated lymphoid tissue: a new site of local immunity. Curr. Opin. Lipidol. 12:547-53
167. Savino W, Villa-Verde DM, Lannes-Vieira J. 1993. Extracellular matrix proteins in intrathymic T-cell migration and differentiation? Immunol. Today 14:158-61
168. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. 2000. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102(8):833-39
169. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, et al. 1998. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 18:1386-92
170. Greaves DR, Channon KM. 2002. Inflammation and immune responses in atherosclerosis. Trends Immunol. 23:535-41
171. Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation 105:1135-43
172. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C. 1997. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest 99:2752-61
173. Whitman SC, Ravisankar P, Daugherty A. 2002. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ. Res. 90:E34-38
174. Caligiuri G, Rudling M, Ollivier V, Jacob MP, Michel JB, et al. 2003. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9:10-17
175. Moatti D, Faure S, Fumeron F, Amara M, Seknadji P, et al. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925-28
176. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, et al. 1999. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J. Clin. Invest. 103:1597-604
177. Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ. 2000. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc. Natl. Acad. Sci. USA 97:7464-69
178. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200-3
179. Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegard J. 2000. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36:303-7
180. Lewthwaite J, Owen N, Coates A, Henderson B, Steptoe A. 2002. Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation 106:196-201
181. Sethna KB, Mistry NF, Dholakia Y, Antia NH, Harboe M. 1998. Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients. Scand. J. Infect. Dis. 30:363-69
182. Beatty WL, Morrison RP, Byrne GI. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-99
183. Bennett MR, Boyle JJ. 1998. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138:3-9
184. Mayr M, Xu Q. 2001. Smooth muscle cell apoptosis in arteriosclerosis. Exp. Gerontol. 36:969-87
185. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, et al. 2001. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104:2649-52
186. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. 1999. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99:348-53
187. Mallat Z, Tedgui A. 2001. Current perspective on the role of apoptosis in atherothrombotic disease. Circ. Res. 88:998-1003
188. Mesri M, Altieri DC. 1999. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J. Biol. Chem. 274:23111-18
189. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, et al. 2002. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 22:1662-67
190. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore JR, Caligiuri G, et al. 1996. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 94:2373-80
191. Fong IW, Chiu B, Viira E, Tucker W, Wood H, Peeling RW. 2002. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. J. Infect. Dis. 186:1469-73
192. Klegeris A, Singh EA, McGeer PL. 2002. Effects of C-reactive protein and pentosan polysulphate on human complement activation. Immunology 106:381-88
193. Zwaka TP, Hombach V, Torzewski J. 2001. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103:1194-97
194. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, et al. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94:1931-36
195. Reul RM, Fang JC, Denton MD, Geehan C, Long C, et al. 1997. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64:1765-74
196. Malik N, Greenfield BW, Wahl AF, Kiener PA. 1996. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156:3952-60
197. Miller DL, Yaron R, Yellin MJ. 1998. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J. Leukoc. Biol. 63:373-79
198. Schonbeck U, Libby P. 2001. The CD40/CD154 receptor/ligand dyad. Cell Mol. Life Sci. 58:4-43
199. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, et al. 1999. Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5:1313-16
200. Ludewig B, Henn V, Schroder JM, Graf D, Kroczek RA. 1996. Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. Eur. J. Immunol. 26:3137-43
201. Schonbeck U, Libby P. 2001. CD40 signaling and plaque instability. Circ. Res. 89:1092-103
202. Aukrust P, Muller F, Ueland T, Berget T, Aaser E, et al. 1999. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614-20
203. Amberger A, Hala M, Saurwein-Teissl M, Metzler B, Grubeck-Loebenstein B, et al. 1999. Suppressive effects of antiinflammatory agents on human endothelial cell activation and induction of heat shock proteins. Mol. Med. 5:117-28
204. Miller LW. 2002. Cardiovascular toxicities of immunosuppressive agents. Am. J. Transplant. 2:807-18
205. Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, et al. 2003. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23:58-63
206. Jurgens G, Xu QB, Huber LA, Bock G, Howanietz H, et al. 1989. Promotion of lymphocyte growth by high density lipoproteins (HDL). Physiological significance of the HDL binding site. J. Biol. Chem. 264(15):8549-56
207. Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, et al. 2001. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 103:1071-75
208. Veres A, Szamosi T, Ablonczy M, Szamosi T Jr, Singh M, et al. 2002. Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease. Eur. J. Clin. Invest. 32:405-10
209. Hoppichler F, Koch T, Dzien A, Gschwandtner G, Lechleitner M. 2000. Prognostic value of antibody titre to heat-shock protein 65 on cardiovascular events. Cardiology 94:220-23
210. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. 1998. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur. Heart J. 19:387-94
211. Prohaszka Z, Duba J, Horvath L, Csaszar A, Karadi I, et al. 2001. Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur. J. Clin. Invest. 31:285-92
212. Veres A, Fust G, Smieja M, McQueen M, Horvath A, et al. 2002. Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.
213. Gromadzka G, Zielinska J, Ryglewicz D, Fiszer U, Czlonkowska A. 2001. Elevated levels of anti-heat shock protein antibodies in patients with cerebral ischemia. Cerebrovasc. Dis. 12:235-39
214. Huittinen T, Leinonen M, Tenkanen L, Manttari M, Virkkunen H, et al. 2002. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler. Thromb. Vasc. Biol. 22:431-37
215. Ciervo A, Visca P, Petrucca A, Biasucci LM, Maseri A, Cassone A. 2002. Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin. Diagn. Lab. Immunol. 9:66-74
216. Pockley AG, de Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J. 2002. Circulating heat shock protein and heat shock protein antibody levels in established hyp. J. Hypertens. 20(9):1815-20
217. Kramer J, Harcos P, Prohaszka Z, Horvath L, Karadi I, et al. 2000. Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases. Stroke 31:2648-52
218. Zhu J, Quyyumi AA, Wu H, Csako G, Rott D, et al. 2003. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23(6):1055-59
219. Swanson SJ, Rosenzweig A, Seidman JG, Libby P. 1994. Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. Arterioscler. Thromb. Vasc. Biol. 14:1210-14
220. Oksenberg JR, Stavri GT, Jeong MC, Garovoy N, Salisbury JR, Erusalimsky JD. 1997. Analysis of the T-cell receptor repertoire in human atherosclerosis. Cardiovasc. Res. 36:256-67